Quantifying US healthcare provider preferences for the treatment of post-transplant cytomegalovirus infection using a discrete choice experiment.
Saved in:
| Title: | Quantifying US healthcare provider preferences for the treatment of post-transplant cytomegalovirus infection using a discrete choice experiment. |
|---|---|
| Authors: | Raglow Z; University of Michigan, Ann Arbor, Michigan, USA., Kaul D; University of Michigan, Ann Arbor, Michigan, USA., Rodriguez AM; IQVIA, Madrid, Spain., Oliveira Gonçalves AS; IQVIA, Lisbon, Portugal., Henry-Szatkowski M; IQVIA, Courbevoie, France., Ginchereau Sowell F; IQVIA, New York, New York, USA., Bullano M; Takeda Pharmaceuticals USA, Inc, Lexington, Massachusetts, USA., Gelone DK; Takeda Pharmaceuticals USA, Inc, Lexington, Massachusetts, USA., Schultz BG; Takeda Pharmaceuticals USA, Inc, Lexington, Massachusetts, USA. |
| Source: | Current medical research and opinion [Curr Med Res Opin] 2026 Mar; Vol. 42 (3), pp. 529-539. Date of Electronic Publication: 2026 May 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1473-4877 |
|---|---|
| DOI: | 10.1080/03007995.2026.2676335 |
